Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page
- Check2 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2, reflecting a minor update to the page version without changing its content.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page now includes related topics such as Type 2 diabetes and MedlinePlus Genetics, adding links to genetics-related health information.SummaryDifference0.2%

- Check17 days agoChange DetectedThe Study Details page now includes Manfredi Rizzo as part of the study record information and adds new navigation items such as How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment label. Legacy text such as Last known status was, Verified, Manfredi Rizzo, University of Palermo, Intervention / Treatment, and the prior Revision: v3.5.5 has been removed, with Revision: v3.6.0 introduced.SummaryDifference2%

- Check24 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page. No actual study data or essential content changes are introduced.SummaryDifference0.1%

- Check31 days agoChange DetectedRemoved the 'Type 2 diabetes' condition from the page’s Conditions section. The related topics header and the MedlinePlus Genetics entry were also removed, affecting navigation and external-resource links.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision upgraded from v3.5.3 to v3.5.4, signaling a small internal update to the page’s tooling. No substantive content changes to the study details are indicated by this update.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.